Leveraging hand-crafted radiomics on multicenter FLAIR MRI for predicting disability worsening in people with multiple sclerosis
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, leading to varying degrees of functional impairment. Conventional tools, such as the Expanded Disability Status Scale (EDSS), lack sensitivity to subtle disease worsening. Radiomics provides a quantitative imaging approach to address this limitation. This study applied machine learning (ML) and radiomics features from T2-weighted Fluid-Attenuated Inversion Recovery (FLAIR) magnetic resonance imaging (MRI) to predict disability worsening in MS. Methods: A retrospective analysis was performed on real-world data from 247 PwMS across two centers. Disability worsening was defined as a change in EDSS over two years. FLAIR MRIs underwent preprocessing and super-resolution reconstruction to enhance low-resolution images. White matter lesions (WML) were segmented using the Lesion Segmentation Toolbox (LST), and tissue segmentation was performed using sequence Adaptive Multimodal Segmentation. Radiomics features from WML and normal-appearing white matter (NAWM) were extracted using Pyradiomics, harmonized with Longitudinal ComBat, followed by recursive feature elimination for feature selection. Elastic Net, Balanced Random Forest (BRFC), and Light Gradient-Boosting Machine (LGBM) models were trained and evaluated. Results: The LGBM model with harmonized radiomics and clinical features outperformed the clinical-only model, achieving a test area under the precision-recall curve (PR AUC) of 0.20 and a receiver operating characteristic area under the curve (ROC AUC) of 0.64. Key predictive features, among others, included Gray-Level Co-Occurrence Matrix (GLCM) maximum probability (WML) and Gray-Level Dependence Matrix (GLDM) dependence non-uniformity (NAWM). However, short-term longitudinal changes showed limited predictive power (PR AUC = 0.11, ROC AUC = 0.69). Conclusion: These findings highlight the potential of ML-driven radiomics in predicting disability worsening, warranting validation in larger, balanced datasets and exploration of advanced deep learning approaches.
Source: Frontiers in Neuroscience
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
Awards: G1260320607, Optimal treatment for patients with solid tumours in Europe through Artificial intelligence, G4533209236, A European Cancer Image Platform Linked to Biological and Health Data for Next-Generation Artificial Intelligence and Precision Medicine in Oncology, Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer, G5810721675, G588901241, The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics, G6531483789, Accelerating the lab to market transition of AI tools for cancer management, International Clinical Validation of Radiomics Artificial Intelligence for Breast Cancer Treatment Planning, G7770515289, AI powered Data Curation & Publishing Virtual Assistant, Real-world-data Enabled Assessment for heaLth regulatory decision-Making, New kids on the block: Improving the care of people with multiple sclerosis by introducing "RADIOMICS" and "EPOMICS".
OpenAlex ID: W4415664458
